Skip to main content
Equibles
PSNL logo

PSNL · Personalis, Inc.

Track PSNL — free

Use PSNL with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$16.67 -0.39 (-2.29%) At close · Sep 2
Russell 2000 member Rebalance outlook locked
Market Cap
$1.82B
Shares
106.80M

PSNL metrics

67 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$17.06
Market cap
$1.82B

Price action

19 metrics
Price change (1W)
-1.1%
Price change (30D)
+29.2%
Price change (3M)
+53.1%
Price change (6M)
+96.8%
Price change (YTD)
+114.3%
Price change (1Y)
+248.9%
Trailing year
Price change (5Y)
-22.1%
52-week high
$18.38
52-week low
$4.81
Change from 52-week high
-7.2%
Change from 52-week low
+254.7%
Annualized volatility
92.5%
Beta
3.0
RSI (14D)
63.4
Price vs SMA 50
+20.2%
Price vs SMA 200
+75.1%
Avg volume (3M)
4.17M
Relative volume
0.9
Average dollar volume
$57.69M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
106.80M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
26.2×
reciprocal yield 3.8%
P / book
7.7
reciprocal yield 12.9%
FCF yield
-5.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-5.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-20

Profitability

9 metrics
Gross margin
22.7%
Operating margin
-164.1%
Trailing 12 months
Net margin
-153.8%
Gross profit (TTM)
$22.08M
Operating profit (TTM)
−$114.31M
Net income (TTM)
−$107.18M
Trailing 12 months
Diluted EPS (TTM)
$-1.09
FCF margin
-144.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-34.48

Growth

11 metrics
Revenue growth YoY
+30.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$69.67M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+19.1%
Year over year · more shares
Revenue CAGR (3Y)
+2.3%
Revenue CAGR (5Y)
-2.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-45.6%
Return on assets
-34.3%
Debt / equity
—
Current ratio
5.3
EBITDA (TTM)
−$104.60M
Free cash flow (TTM)
−$100.97M
Quick ratio
5.3
Interest coverage
-536.7
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$93.97M
Total assets
$312.13M
Total debt
$19.04M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$92.30M
Capital expenditures (TTM)
$8.68M
R&D (TTM)
$56.12M
SG&A (TTM)
$67.03M
Stock compensation (TTM)
$10.91M
R&D / revenue
80.5%
Stock compensation / revenue
15.7%

Ownership (13F)

3 metrics
13F filers
158
13F filer change QoQ
+15
Institutional ownership
80.6%

Short interest

3 metrics
Short interest
7.9%
Latest settlement · 3.6 days to cover
Days to cover
3.6d
Short-squeeze score
71 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$5.08M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1527753 CUSIP 71535D106 13F (30d) 138 filings 136 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)